Skip to Main Content

Paper Details

Proteogenomic analysis of Inhibitor of Differentiation 4 (ID4) in basal-like breast cancer.
Breast Cancer Res
7
2020
BLBC, BRCA1, BRCA1-mutant BLBC, Basal-like breast cancer, DNA damage repair deficiency, DNA repair proteins, H2AX, HGSOC, ID4, Inhibitor of Differentiation 4, Inhibitor of differentiation 4, MDC1, Patients, RNA, basal, basal-like breast cancer, cell line models, chromatin, fragile chromatin sites, genomic binding sites, helix-loop-helix transcriptional regulator, high, high-, high-grade tumours, mediator of DNA damage checkpoint protein 1, ovarian cancer, patients, sporadic BLBC
Author NameAffiliation
Peter T SimpsonCentre for Clinical Research, The University of Queensland
Peter T SimpsonCentre for Clinical Research, The University of Queensland
Sunil R LakhaniCentre for Clinical Research, The University of Queensland
Sunil R LakhaniThe Royal Brisbane and Women's Hospital
Sunil R LakhaniCentre for Clinical Research, The University of Queensland
Sunil R LakhaniThe Royal Brisbane and Women's Hospital
Kaylene J SimpsonPeter MacCallum Cancer Centre
Kaylene J SimpsonUniversity of Melbourne
Kaylene J SimpsonPeter MacCallum Cancer Centre
Kaylene J SimpsonUniversity of Melbourne
Mark J CowleyThe Kinghorn Cancer Centre and Cancer Research Division, Garvan Institute of Medical Research
Mark J CowleySt Vincent's Clinical School
Jason S CarrollThe University of Cambridge
  • 1 - 13

Datasets

Release 1.2